Lv11
20 积分 2026-08-02 加入
First-Line Zongertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer
2小时前
待确认
First-Line Zongertinib in Advanced HER2-Mutant Non–Small-Cell Lung Cancer
2小时前
已关闭
Emerging Targeted Therapies for HER2-Mutant NSCLC
23小时前
已完结
Alectinib as neoadjuvant treatment in potentially resectable stage III ALK-positive NSCLC: Final analysis of ALNEO phase II trial (GOIRC-01-2020-ML42316)
18天前
已完结
Tracking the Evolution of Non-Small-Cell Lung Cancer
1个月前
已完结
The role of APOBEC in early-stage epidermal growth factor receptor-mutant non-small cell lung cancer
2个月前
已完结
Comprehensive Characterization of Somatic Mutation Timing Reveals the Evolutionary Trajectory of Lung Adenocarcinoma in Chinese Patients
2个月前
已完结
The Genomic Landscape of NSCLC in Systemic Sclerosis Reveals Frequent TP53 Mutations and a Paucity of Actionable Oncogenes
2个月前
已完结
Insertional activity of human Alu and L1 retrotransposons is associated with DNA repair pathways and genome instability in cancer
2个月前
已完结
APOBEC3A drives resistance
3个月前
已完结
皖公网安备34019202002308
